search
Back to results

Estimation of the Dietary Requirement for Vitamin D in Ethnic Groups

Primary Purpose

Vitamin D Deficiency, Immune Health, Muscle Function

Status
Recruiting
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
Vitamin D Supplement
Sponsored by
University of Surrey
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Vitamin D Deficiency

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria: British white European, black African/Caribbean, or South Asian (self-reported) Living in England for >2 months Aged >18 years No significant health issues English or Urdu speaker Exclusion Criteria: Medical condition or history which might impact study measurements (e.g., ischaemic heart disease, type 1 and type 2 diabetes, thyroid disease, osteoporosis, haematological disease, malignancy) Medications known to affect vitamin D metabolism (i.e., hormone replacement therapy, anti-oestrogens treatment, antiepileptic drugs, and breast cancer treatment) Pregnant or planning pregnancy during the study period Regular use of sun beds Having a sun holiday one month prior to commencing study or plans for a sun holiday within the study period. A sun holiday is generally defined as a holiday in a sunny resort outside of the UK. The researchers will assess this on a case-by-case basis depending on the time of year and expected weather conditions Reported participation in another clinical trial occurring simultaneously Previous intolerance or allergic reaction to vitamin D

Sites / Locations

  • Faculty of Health and Medical SciencesRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Active Comparator

Active Comparator

Active Comparator

Arm Label

Vitamin D Supplement 400 IU

Vitamin D Supplement 1000 IU

Vitamin D Supplement 2000 IU

Arm Description

400 IU (10 µg) of Vitamin D3

1000 IU (25 µg) of Vitamin D3

2000 IU (50 µg) of Vitamin D3

Outcomes

Primary Outcome Measures

Concentration of serum 25(OH)D (nmol/L)
A blood sample will be analysed using liquid chromatography tandem mass spectroscopy (LC-MS). Dose-response change in serum 25(OH)D will be measured in nmol/L.

Secondary Outcome Measures

Anthropometric measurements - weight (kg)
Weight (kg)
Anthropometric measurements - height (m)
Height (m)
Anthropometric measurements - height (cm)
Height (cm)
Anthropometric measurements - waist circumference (cm)
Waist circumference measurement (cm)
Anthropometric measurements - hip circumference (cm)
Hip circumference measurement (cm)
Concentration of serum calcium (nmol/L)
Measure dose-response change in serum calcium measured in nmol/L
Concentration of plasma parathyroid hormone (PTH) (pg/mL)
Measure dose-response change in plasma parathyroid hormone (PTH) measured in pg/mL
Concentration of serum albumin (g/L)
Measure dose-response change in serum albumin measured in g/L
Concentration of C-Reactive Protein (CRP) (mg/L)
Measure dose-response change in CRP measured in mg/L
Complete blood count
Measure change in complete blood count
Change in immune parameters
Measure change in peripheral blood mononuclear cell (PBMC) profile
Number of participants with Acute Respiratory Tract Infections (ARTIs)
Measure the frequency of ARTIs using a validated questionnaire
Muscular strength using a handgrip strength test (kg)
Muscular strength measured using a dynamometer (measured to the nearest 0.1kg). The participant will squeeze the dynamometer with maximum effort for 5 seconds.
Muscular strength and endurance using a sit-to-stand test
Number of sit to stands in 30 seconds
Blood analytes - micronutrient status
Measure dose-response change in micronutrient status from blood samples
Blood analytes - lipid profile (mg/dL)
Measure change in lipid profile from blood samples measured in mg/dL
Vitamin D consumption from diet
Vitamin D intake will be measured through a 4-day food diary which participants will fill out for 4 day at home before and after the study.
Physical activity questionnaire
Assess level of physical activity using an International Physical Activity Questionnaire (short form)
Sun exposure behaviour questionnaire
Measures amount of time spent in the sun (often, occasionally, never) and what parts of the body are exposed (head, hands, arms, legs, torso) over summer, spring, autumn and winter. Also questions any summer holidays abroad, in what month, what country was visited, number of hours of sun per day and what body parts were exposed (head, hands, arms, legs, torso)
UVB sun exposure
Sun exposure will be measured by a dosimeter, which measures UVB exposure. Participants wear this like a badge for 4 days before and after the study.
Lifestyle questionnaire
Measures: - Skin type (Fitzpatrick scale) Questions: Questions what ethnicity they identify with, Holidays abroad, Education, Origin, Health, Pregnancy, Sun behaviours (what body parts are usually exposed to the sun, clothing, sun bathing, sunscreen use, sun bed use), Smoking, Drinking, Recreational drug use, Knowledge around vitamin D, supplement use, Milk, egg, oily fish and liver consumption

Full Information

First Posted
September 20, 2023
Last Updated
September 27, 2023
Sponsor
University of Surrey
Collaborators
University of Reading
search

1. Study Identification

Unique Protocol Identification Number
NCT06067477
Brief Title
Estimation of the Dietary Requirement for Vitamin D in Ethnic Groups
Official Title
Estimation of the Dietary Requirement for Vitamin D in Ethnic Groups: a Double-blind, Randomised, Dose-response Trial
Study Type
Interventional

2. Study Status

Record Verification Date
September 2023
Overall Recruitment Status
Recruiting
Study Start Date
October 2023 (Anticipated)
Primary Completion Date
September 2025 (Anticipated)
Study Completion Date
September 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Surrey
Collaborators
University of Reading

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The aim of this study is to perform a double-blind, randomised, dose-response trial of vitamin D3 supplementation in United Kingdom (UK)-dwelling adults of white European, South Asian, and black African/Caribbean ethnicity to investigate the distribution of dietary intakes needed to maintain adequate vitamin D status in winter, as indicated by serum 25(OH)D concentrations at ranges of >25 to 50 nmol/L. In addition, this study will investigate the effect of vitamin D3 supplementation on immune health, muscular strength, and overall health.
Detailed Description
The aim of this study is to perform a double-blind, randomised, dose-response trial of vitamin D3 supplementation in United Kingdom (UK)-dwelling adults of white European, South Asian, and black African/Caribbean ethnicity to investigate the distribution of dietary intakes needed to maintain adequate vitamin D status in winter, as indicated by serum 25(OH)D concentrations at ranges of >25 to 50 nmol/L. In addition, this study will investigate the effect of vitamin D3 supplementation on immune health, muscular strength, and overall health. Recruited participants will be randomised to take 400, 1000, or 2000 IU for 12 weeks. Fasting blood samples collected at baseline and 12 weeks will measure biochemical markers of vitamin D status (serum 25(OH)D, calcium, parathyroid hormone, albumin), lipid profile, ferritin, micronutrient status, and immune and inflammatory biomarkers. Muscular strength will be measured using sit-to-stand and grip strength tests. Questionnaires, food diaries, and dosimeters will be used to gather data on lifestyle, physical activity, dietary intake, and sun exposure.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Vitamin D Deficiency, Immune Health, Muscle Function

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Recruited participants will be randomised to take 400,1000, or 2000 IU for 12 weeks.
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
114 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Vitamin D Supplement 400 IU
Arm Type
Active Comparator
Arm Description
400 IU (10 µg) of Vitamin D3
Arm Title
Vitamin D Supplement 1000 IU
Arm Type
Active Comparator
Arm Description
1000 IU (25 µg) of Vitamin D3
Arm Title
Vitamin D Supplement 2000 IU
Arm Type
Active Comparator
Arm Description
2000 IU (50 µg) of Vitamin D3
Intervention Type
Dietary Supplement
Intervention Name(s)
Vitamin D Supplement
Intervention Description
Vitamin D Supplement
Primary Outcome Measure Information:
Title
Concentration of serum 25(OH)D (nmol/L)
Description
A blood sample will be analysed using liquid chromatography tandem mass spectroscopy (LC-MS). Dose-response change in serum 25(OH)D will be measured in nmol/L.
Time Frame
Baseline and 12 weeks
Secondary Outcome Measure Information:
Title
Anthropometric measurements - weight (kg)
Description
Weight (kg)
Time Frame
Baseline and 12 weeks
Title
Anthropometric measurements - height (m)
Description
Height (m)
Time Frame
Baseline and 12 weeks
Title
Anthropometric measurements - height (cm)
Description
Height (cm)
Time Frame
Baseline and 12 weeks
Title
Anthropometric measurements - waist circumference (cm)
Description
Waist circumference measurement (cm)
Time Frame
Baseline and 12 weeks
Title
Anthropometric measurements - hip circumference (cm)
Description
Hip circumference measurement (cm)
Time Frame
Baseline and 12 weeks
Title
Concentration of serum calcium (nmol/L)
Description
Measure dose-response change in serum calcium measured in nmol/L
Time Frame
Baseline and 12 weeks
Title
Concentration of plasma parathyroid hormone (PTH) (pg/mL)
Description
Measure dose-response change in plasma parathyroid hormone (PTH) measured in pg/mL
Time Frame
Baseline and 12 weeks
Title
Concentration of serum albumin (g/L)
Description
Measure dose-response change in serum albumin measured in g/L
Time Frame
Baseline and 12 weeks
Title
Concentration of C-Reactive Protein (CRP) (mg/L)
Description
Measure dose-response change in CRP measured in mg/L
Time Frame
Baseline and 12 weeks
Title
Complete blood count
Description
Measure change in complete blood count
Time Frame
Baseline and 12 weeks
Title
Change in immune parameters
Description
Measure change in peripheral blood mononuclear cell (PBMC) profile
Time Frame
Baseline and 12 weeks
Title
Number of participants with Acute Respiratory Tract Infections (ARTIs)
Description
Measure the frequency of ARTIs using a validated questionnaire
Time Frame
12 weeks
Title
Muscular strength using a handgrip strength test (kg)
Description
Muscular strength measured using a dynamometer (measured to the nearest 0.1kg). The participant will squeeze the dynamometer with maximum effort for 5 seconds.
Time Frame
Baseline and 12 weeks
Title
Muscular strength and endurance using a sit-to-stand test
Description
Number of sit to stands in 30 seconds
Time Frame
Baseline and 12 weeks
Title
Blood analytes - micronutrient status
Description
Measure dose-response change in micronutrient status from blood samples
Time Frame
Baseline and 12 weeks
Title
Blood analytes - lipid profile (mg/dL)
Description
Measure change in lipid profile from blood samples measured in mg/dL
Time Frame
Baseline and 12 weeks
Title
Vitamin D consumption from diet
Description
Vitamin D intake will be measured through a 4-day food diary which participants will fill out for 4 day at home before and after the study.
Time Frame
Baseline and 12 weeks
Title
Physical activity questionnaire
Description
Assess level of physical activity using an International Physical Activity Questionnaire (short form)
Time Frame
Baseline
Title
Sun exposure behaviour questionnaire
Description
Measures amount of time spent in the sun (often, occasionally, never) and what parts of the body are exposed (head, hands, arms, legs, torso) over summer, spring, autumn and winter. Also questions any summer holidays abroad, in what month, what country was visited, number of hours of sun per day and what body parts were exposed (head, hands, arms, legs, torso)
Time Frame
Baseline
Title
UVB sun exposure
Description
Sun exposure will be measured by a dosimeter, which measures UVB exposure. Participants wear this like a badge for 4 days before and after the study.
Time Frame
Baseline and 12 weeks
Title
Lifestyle questionnaire
Description
Measures: - Skin type (Fitzpatrick scale) Questions: Questions what ethnicity they identify with, Holidays abroad, Education, Origin, Health, Pregnancy, Sun behaviours (what body parts are usually exposed to the sun, clothing, sun bathing, sunscreen use, sun bed use), Smoking, Drinking, Recreational drug use, Knowledge around vitamin D, supplement use, Milk, egg, oily fish and liver consumption
Time Frame
Baseline

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: British white European, black African/Caribbean, or South Asian (self-reported) Living in England for >2 months Aged >18 years No significant health issues English or Urdu speaker Exclusion Criteria: Medical condition or history which might impact study measurements (e.g., ischaemic heart disease, type 1 and type 2 diabetes, thyroid disease, osteoporosis, haematological disease, malignancy) Medications known to affect vitamin D metabolism (i.e., hormone replacement therapy, anti-oestrogens treatment, antiepileptic drugs, and breast cancer treatment) Pregnant or planning pregnancy during the study period Regular use of sun beds Having a sun holiday one month prior to commencing study or plans for a sun holiday within the study period. A sun holiday is generally defined as a holiday in a sunny resort outside of the UK. The researchers will assess this on a case-by-case basis depending on the time of year and expected weather conditions Reported participation in another clinical trial occurring simultaneously Previous intolerance or allergic reaction to vitamin D
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Abigail Bournot, PhD
Phone
01483689222
Email
a.bournot@surrey.ac.uk
First Name & Middle Initial & Last Name or Official Title & Degree
Susan Lanham-New
Phone
01483686476
Email
s.lanham-new@surrey.ac.uk
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Abigail Bournot
Organizational Affiliation
University of Surrey
Official's Role
Principal Investigator
Facility Information:
Facility Name
Faculty of Health and Medical Sciences
City
Guildford
ZIP/Postal Code
GU2 7XH
Country
United Kingdom
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Abigail Bournot, PhD
Phone
01483689222
Email
a.bournot@surrey.ac.uk
First Name & Middle Initial & Last Name & Degree
Susan Lanham-New
Phone
01483686476
Email
s.lanham-new@surrey.ac.uk

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Estimation of the Dietary Requirement for Vitamin D in Ethnic Groups

We'll reach out to this number within 24 hrs